MINNEAPOLIS, Aug. 16, 2018 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that its management team will be presenting at the 13th Annual Wells Fargo Securities Healthcare Conference on September 6, 2018 at the Westin Copley Place in Boston, Massachusetts.
Inspire is scheduled to present at 11:30 a.m. Eastern Time. The presentation will be accessible via a live webcast at: https://cc.talkpoint.com/well001/090518a_as/?entity=23_3F6QX8G.
A webcast replay of the presentation will be available on the Investor section of Inspire’s website at www.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact: